HIV / AIDS in the News

Lawmakers from across the globe meet to fight HIV/AIDS - Erasing 76 Crimes

 

Gilead scores clinical trial win toward moving HIV patients from multiple-drug regimen to single tablet - The Business Journals

 

Gilead Looks To Simplify HIV Treatment By Combining Two Leading Drugs in One Pill - BioSpace

 

GILD's Investigational Regimen for HIV Treatment Meets Primary Goal - TradingView

 

GILD's Investigational Regimen for HIV Treatment Meets Primary Goal - Yahoo Finance

 

Gilead’s HIV single-pill combo meets primary endpoints in pivotal trial - Clinical Trials Arena

 

Gilead’s HIV single-pill combo meets primary endpoints in pivotal trial - Yahoo

 

Is Gilead’s Successful Phase 3 HIV Regimen Trial Shifting the Investment Case for GILD? - Yahoo Finance

 

SCOPE: Community Insights on the HIV and STIs Biomedical Prevention Pipeline PrEP Implementation and Combination Prevention Advocacy —Reports - European AIDS Treatment Group

 

UNAIDS releases updated guidelines for conducting National AIDS Spending Assessments - UNAIDS

 

NHS to offer long-acting HIV prevention injection to more than 1,000 at-... - facilitiesmanagement-now.com

 

TaiMed Biologics - businessfocusmagazine.com

 

How T Cells Are Defining the Future of HIV Therapies and Beyond - amfAR, The Foundation for AIDS Research

 

Accused rapist wanted to give men HIV, court hears - AOL.com

 

Novel HIV-1 fusion peptide immunogens using glycan-engineered alphavirus-like particles - Nature

 

EDITORIAL | Spotlight launches new HIV dashboard - spotlightnsp.co.za

 

Prevalence of Diabetes Mellitus Among People Living With HIV and Receiving Antiretroviral Therapy at Muhimbili National Hospital in Tanzania - Cureus

 

MOH Allocates RM8 Mil For HIV Programme In Transition From International Funding - CodeBlue

 

Opportunities for Low-Barrier HIV Testing in the U.S. Deep South: Findings from a Survey in Alabama - springermedicine.com

 

HCV core antigen testing accurately detects acute HCV in patients with HIV - European AIDS Treatment Group

 

HIV Pre-Exposure Prophylaxis Service Cascade and Risk Factors Associated with Loss to Follow-Up Among Key Populations in Indonesia: Data from a Real-World Pilot Implementation 2021–2023 - springermedicine.com

 

Iron supplement absorption preserved in children with HIV and boosted by prebiotics - European AIDS Treatment Group

 

Gilead’s investigational single-tablet regimen of bictegravir and lenacapavir for HIV-1 treatment meets primary endpoint in Phase 3 ARTISTRY-1 trial - European AIDS Treatment Group

 

Highlights from The Liver Meeting 2025 - European AIDS Treatment Group

 

Vanderbilt Institute for Global Health marks 20 years - VUMC News

 

History of the AIDS Crisis: A Timeline - Britannica

 

In under a year, Trump administration has threatened decades of progress in global fight against HIV/AIDS - prismreports.org

 

Unsuspected drug shortage is impacting the German HIV PrEP supply - results of a cross-sectional survey show: majority of PrEP users had to stop or switch to on-demand PrEP and higher unmet PrEP demand among women, diverse individuals, and those in - BMC…

 

Gilead's One-Pill HIV Treatment Shows Promise In Late-Stage Trial - Gilead Sciences (NASDAQ:GILD) - Benzinga

 

Gilead stock rises after positive HIV treatment trial results - Investing.com